Teleflex, Inc. (TFX) Tops Q2 EPS by 17c; Raises Outlook

Teleflex, Inc. (NYSE: TFX) reported Q2 EPS of $1.51, $0.17 better than the analyst estimate of $1.34. Revenue for the quarter came in at $468.21 million versus the consensus estimate of $447.81 million.

Teleflex, Inc. sees FY2014 EPS of $5.45-$5.60, versus prior guidance of $5.35-$5.55 and the consensus of $5.51.

“Despite the impact of one less selling day in the second quarter of 2014 as compared to the prior year period, Teleflex delivered double-digit constant currency revenue and adjusted earnings per share growth,” said Benson Smith, Chairman, President and Chief Executive Officer. “Our second quarter performance was aided by the contribution from the acquisitions of Vidacare and Mayo Healthcare, an improvement in the average selling price of products, the introduction of new products to the market and a slight improvement in the sales of existing products resulting from a modest improvement in end-market utilization.”

Added Mr. Smith, “Based on the Company’s performance during the first six months of 2014, and our outlook for the remainder of the year, we are reaffirming our full year constant currency revenue growth guidance range of 7% to 9%, and increasing our full year adjusted diluted earnings per share guidance range from $5.35 to $5.55 to $5.45 to $5.60.”

For earnings history and earnings-related data on Teleflex, Inc. (TFX) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
• Netlist (NLST) Misses Q1 EPS by 1c